Pharmacodynamics: Drug-receptors
18 Questions
8 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary function of ligand-gated ion channels once a ligand binds?

  • To bind specifically to hydrophilic ligands
  • To phosphorylate other proteins in the cell
  • To form a channel that allows ions to flow passively (correct)
  • To inhibit the flow of ions across the membrane
  • Which type of receptor typically contains an enzymatic domain that is a protein kinase?

  • G-protein coupled receptors
  • Ligand-gated ion channels
  • Intracellular receptors
  • Enzyme-coupled receptors (correct)
  • What triggers the activating change in G-protein coupled receptors once a ligand binds?

  • The formation of ion channels
  • A conformational change in the receptor (correct)
  • The release of tyrosine kinase
  • The production of GDP
  • What must happen to the alpha subunit of G proteins for it to become active?

    <p>It must release GDP and bind GTP</p> Signup and view all the answers

    What characteristic distinguishes G-protein coupled receptors from other types of receptors?

    <p>They consist of seven transmembrane segments</p> Signup and view all the answers

    Intracellular receptors primarily bind to which type of ligands?

    <p>Small and hydrophobic ligands</p> Signup and view all the answers

    Enzyme-coupled receptors undergo a conformational change primarily to:

    <p>Create high-affinity binding sites for second messengers</p> Signup and view all the answers

    Which of the following statements about intracellular receptors is true?

    <p>They require a ligand to enter the nucleus.</p> Signup and view all the answers

    Which second messenger is activated by DAG?

    <p>Protein kinase C</p> Signup and view all the answers

    What does the term 'potency' refer to in pharmacology?

    <p>The amount of medication needed to elicit an effect</p> Signup and view all the answers

    How is efficacy defined among medications?

    <p>The maximal effect a medication can produce</p> Signup and view all the answers

    What happens at the EC50 point on a dose-response curve?

    <p>50% of the maximum effect is reached</p> Signup and view all the answers

    In a dose-response curve, what does a curve closer to the left indicate?

    <p>Higher potency of the medication</p> Signup and view all the answers

    Which of the following G proteins inhibits adenylate cyclase?

    <p>Gi</p> Signup and view all the answers

    What is the primary function of phospholipase C when activated by Gq proteins?

    <p>To cleave PIP2 into IP3 and DAG</p> Signup and view all the answers

    Which medication characteristic does not affect affinity?

    <p>Concentration of the medication</p> Signup and view all the answers

    What shape does a typical dose-response curve take?

    <p>S-shaped (sigmoidal)</p> Signup and view all the answers

    Between medications C and D, which is described as more efficacious?

    <p>Medication C, as it achieves a higher maximal effect</p> Signup and view all the answers

    Study Notes

    Intracellular Receptors

    • Located in the cytoplasm or nucleus of cells
    • Bind to small, hydrophobic ligands, such as steroids
    • Receptor-ligand complex binds to specific DNA sequences
    • This interaction activates or inhibits specific genes

    Cell-Surface Receptors

    • Embedded in the plasma membrane
    • Bind to ligands that are too large or hydrophilic to pass through the membrane
    • Three main types: ligand-gated ion channels, enzyme-coupled receptors, and G-protein coupled receptors

    Ligand-gated Ion Channels (Ionotropic Receptors)

    • Form channels or pores that are closed in the absence of a ligand
    • Binding of a ligand opens the channel, allowing ions (chloride, calcium, sodium, potassium) to pass through
    • Ions flow passively down their concentration gradients
    • This triggers downstream signaling pathways

    Enzyme-coupled Receptors

    • Usually single-pass transmembrane proteins
    • Extracellular domain binds to ligands
    • Intracellular domain has enzymatic activity, typically protein kinase (tyrosine kinase)
    • Ligand binding triggers conformational changes, creating high-affinity binding sites for second messengers
    • Tyrosine kinases phosphorylate second messengers, activating other proteins in the signaling pathway

    G-protein Coupled Receptors (Seven-Pass Transmembrane Receptors)

    • Long proteins with one end outside the cell and seven transmembrane segments
    • Ligand binding on the extracellular end activates guanine nucleotide-binding proteins (G proteins)
    • G proteins have alpha, beta, and gamma subunits
    • Alpha subunit binds to GDP in the inactive state
    • Ligand binding causes the alpha subunit to release GDP and bind GTP
    • This activation causes the alpha subunit to detach and trigger other proteins in the signaling pathway

    Types of G Proteins

    • Gq, Gi, and Gs
    • Each type has a unique alpha subunit
    • Gq activates phospholipase C
    • Gs and Gi stimulate or inhibit adenylate cyclase, respectively

    Second Messengers

    • IP3, DAG, and cAMP
    • Produced by the action of G proteins and their target enzymes
    • IP3 and DAG are produced by phospholipase C
    • cAMP is produced (or inhibited) by adenylate cyclase
    • Activate or inhibit various enzymes and molecular pathways

    Medication-Receptor Interactions

    • Three key principles: affinity, potency, and efficacy

    Affinity

    • Strength of the binding interaction between a medication and its receptor
    • Determined by the chemical bond between the two molecules
    • Higher affinity generally corresponds to a stronger interaction

    Potency

    • Amount of medication needed to produce a specific effect
    • High potency requires a lower dose for a given effect
    • Affinity is directly proportional to potency

    Efficacy

    • Maximum effect a medication can produce
    • Measured by the Emax (maximum response) on a dose-response curve
    • Higher efficacy corresponds to a greater maximum response

    Dose-Response Curve

    • Graph showing the relationship between medication concentration (dose) and the response produced
    • Typically S-shaped (sigmoidal)
    • X-axis: medication concentration (logarithmic scale)
    • Y-axis: response

    EC50

    • Median effective concentration
    • Concentration of medication that produces 50% of the maximum effect (Emax)
    • EC50 is inversely proportional to potency

    Comparing Medications

    • Higher potency corresponds to a lower EC50 on the dose-response curve (curve shifted left)
    • Higher efficacy corresponds to a higher Emax on the dose-response curve (curve shifted upward)

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Explore the fascinating world of cell receptors in this quiz, focusing on intracellular receptors and cell-surface receptors. Learn about their structures, functions, and the mechanisms by which they activate or inhibit specific genes and signaling pathways. Test your knowledge on ligand-gated ion channels and enzyme-coupled receptors.

    More Like This

    Use Quizgecko on...
    Browser
    Browser